483 Paul Harmatz, M.D. Oct 2013

483 Paul Harmatz, M.D. Oct 2013

$119 - Not in Stock

FDA investigators audited the Paul Harmatz, M.D. - Oakland, CA, United States facility and issued inspectional observations (via FDA 483) on 02 Oct 2013.

Product details

  • Category: Human Drugs
  • Inspection end: 02 Oct 2013
  • Location: Oakland, United States
  • FEI: 3004936676
Order